Details
Stereochemistry | RACEMIC |
Molecular Formula | C10H16N2OS |
Molecular Weight | 212.312 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CC1NC(=S)N(CC=C)C1=O
InChI
InChIKey=RATGSRSDPNECNO-UHFFFAOYSA-N
InChI=1S/C10H16N2OS/c1-4-5-12-9(13)8(6-7(2)3)11-10(12)14/h4,7-8H,1,5-6H2,2-3H3,(H,11,14)
Molecular Formula | C10H16N2OS |
Molecular Weight | 212.312 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Albutoin has been shown to have an anticonvulsant activity against clonic and tonic experimental seizures in mice and rats, particularly those induced by pentylenetetrazol. The first report, in 1959, of the clinical use of albutoin indicated that the drug was more effective in tonic-clonic
seizures than in absence seizures. Albutoin was marketed in Europe as CO-ORD and Euprax by Baxter Laboratories. Albutoin was not approved by the United States Food and Drug Administration.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4206927
The low dosage of albutoin (600 mg/day, medication schedule 2) was not more effective than placebo (medication schedule 1) in preventing excess seizures. The high dosage of albutoin (1,200 mg/day, medication schedule 3) had about the same effectiveness as the low dosage of
phenobarbital (150 mg/day, medication schedule 4) in preventing excess seizures.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:54:41 GMT 2023
by
admin
on
Sat Dec 16 16:54:41 GMT 2023
|
Record UNII |
475NGR2DC1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL327235
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
3032361
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
830-89-7
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
SUB05298MIG
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
1449
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
m1481
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | Merck Index | ||
|
106
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
DTXSID0022565
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
C90706
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
475NGR2DC1
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
C006443
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
100000087716
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY | |||
|
Albutoin
Created by
admin on Sat Dec 16 16:54:41 GMT 2023 , Edited by admin on Sat Dec 16 16:54:41 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |